Publication
Title
Restaging after induction therapy for non-small cell lung cancer
Author
Abstract
Patients with persisting involvement of mediastinal lymph nodes after neo-adjuvant therapy have a poor prognosis and do not benefit from surgical resection. Precise restaging after induction treatment is important to determine further treatment and prognosis. Computed tomography and magnetic resonance imaging have a low accuracy in predicting response after induction therapy. Positron emission tomo-graphy has a high sensitivity to detect residual viable disease in the primary turnout but not in the mediastinal. lymph nodes. Invasive staging remains necessary to precisely assess mediastinal response. Remediastinoscopy, although technically difficult, has an accuracy of 80 % and provides histological proof of mediastinal downstaging. In this way, it is a useful procedure to select patients for thoracotomy after induction therapy. The ultimate overall pathologic response can only be determined by thoracotomy with excision of the primary tumour, hilar and mediastinal lymph nodes.
Language
English
Source (journal)
NATO science series. Series I, Life and behavioural sciences
Management
Source (book)
NATO Advanced Research Workshop on New Advances in Thoracic Oncology, APR 28-30, 2002, Olginka, RUSSIA
Publication
2005
ISBN
1-58603-357-3
Volume/pages
350(2005), p. 27-35
ISI
000228717300004
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 03.01.2013
Last edited 06.11.2017
To cite this reference